Not applicableStudy completedNCT00745966What this trial is testingAtypical Antipsychotics in Improvement of Quality of Life in Bipolar DisorderWho this might be right forNaturalisticObservational AstraZeneca 1,000
Early research (Phase 1)Study completedNCT00791622What this trial is testingQT and QTc Intervals in Patients Administered Extended Release Paliperidone or QuetiapineWho this might be right forSchizophreniaSchizoaffective Disorder Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 110
Not applicableUnknownNCT03996356What this trial is testingClozapine Induced Weight GainWho this might be right forWeight GainAntipsychotic AgentsPharmacogenetics Cwm Taf University Health Board (NHS) 160
Large-scale testing (Phase 3)Study completedNCT01994109What this trial is testingEfficacy and Safety Study of MYOBLOC® in the Treatment of Sialorrhea in Adult SubjectsWho this might be right forSialorrhea Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC 187
Early research (Phase 1)Study completedNCT00892541What this trial is testingThe Potential Effects of Trimethoprim on the Pharmacokinetics of ER OROS PaliperidoneWho this might be right forSchizophrenia Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 30
Post-approval studies (Phase 4)Study completedNCT00137020What this trial is testingClinical Effect Of Cross Titration Of Antipsychotics With Ziprasidone In Schizophrenia Or Schizoaffective DisorderWho this might be right forSchizophreniaPsychotic Disorders Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 294
Large-scale testing (Phase 3)Study completedNCT00518323What this trial is testingA Double-blind, Placebo-controlled Study of the Safety and Efficacy of Paliperidone Extended Release (ER) in the Treatment of Schizophrenia in Adolescent PatientsWho this might be right forSchizophrenia Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 201
Large-scale testing (Phase 3)Ended earlyNCT01129674What this trial is testingA Long-Term, Open-Label, Study on SchizophreniaWho this might be right forSchizophrenia Denovo Biopharma LLC 560
Post-approval studies (Phase 4)Ended earlyNCT00767715What this trial is testingA Study in the Treatment of Acute ManiaWho this might be right forBipolar Disorder Eli Lilly and Company 11
Testing effectiveness (Phase 2)Ended earlyNCT00279409What this trial is testingTreatment of Children With ADHD Who do Not Fully Respond to StimulantsWho this might be right forAttention Deficit Hyperactivity Disorder New York State Psychiatric Institute 10
Not applicableStudy completedNCT00677898What this trial is testingA Patient-Centered Approach to Improve Screening for Side Effects of Second Generation Antipsychotics (SGAs)Who this might be right forSchizophreniaPsychotic Disorders US Department of Veterans Affairs 239
Post-approval studies (Phase 4)Study completedNCT00245206What this trial is testingSide Effects of Newer Antipsychotics in Older AdultsWho this might be right forSchizophreniaAlzheimer's DiseaseDementia Veterans Medical Research Foundation 406
Post-approval studies (Phase 4)Study completedNCT02146547What this trial is testingEuropean Long-acting Antipsychotics in Schizophrenia TrialWho this might be right forSchizophrenia UMC Utrecht 536
Not applicableStudy completedNCT00294008What this trial is testingEvaluate Treatment Adherence in Schizophrenia With Long Acting Risperidone Microspheres (e-STAR)Who this might be right forSchizophreniaTranquilizing AgentsMental Disorders+4 more Janssen Korea, Ltd., Korea 230
Not applicableStudy completedNCT00224276What this trial is testingPrevalence of Diabetes Mellitus Among Patients Treated With Atypical and Conventional AntipsychoticsWho this might be right forSchizophreniaBipolar DisorderDiabetes Mellitus Yale University 100
Post-approval studies (Phase 4)Study completedNCT00576732What this trial is testingThe Effectiveness and Safety of Two Doses of Risperidone in the Treatment of Children and Adolescents With Autistic DisorderWho this might be right forAutistic DisorderAutism Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 96
Not applicableStudy completedNCT01214135What this trial is testingA Retrospective Non-interventional Study to Evaluate the Use of Seroquel Extended Release (XR) and Immediate Release (IR) in the Clinical Practice of Inpatients With SchizophreniaWho this might be right forSchizophrenia AstraZeneca 300
Not applicableStudy completedNCT07371325What this trial is testingEfficacy of Pediococcus Acidilactici as add-on to Antipsychotic Drugs on Metabolic Syndrome Disturbances in First-episode Psychosis and Schizophrenia Spectrum Disorders.Who this might be right forSCHIZOPHRENIA 1 (Disorder)Metabolic AbnormalitiesPostbiotic Supplement Manuel Jesús Cuesta Zurita 36
Post-approval studies (Phase 4)Ended earlyNCT01615185What this trial is testingA Randomized, Double-blind, Comparison of the Efficacy and Safety of Amisulpride Versus Low-dose Amisulpride Plus Low-dose Sulpiride in the Treatment of SchizophreniaWho this might be right forSchizophrenia Kaohsiung Kai-Suan Psychiatric Hospital 96
Testing effectiveness (Phase 2)Study completedNCT00096863What this trial is testingThe MIND Study: Modifying the INcidence of DeliriumWho this might be right forDeliriumCognition Disorders Vanderbilt University 102